Cardiology

Women’s health, CVD and hypertension



ON DEMAND WebinarFinal Programme

CLICK HERE to watch the recorded webinar

Click to listen to the Podcast

Click to download the Infographic

Women’s health, CVD and hypertension

E-learning Modules

Launch: 8 November 2024

Back to Main page

scroll-down-icon

Overview

Hypertensive disorders of pregnancy (HDP) affect 5–10% of all pregnancies and include gestational hypertension, pre-eclampsia, chronic hypertension with superimposed pre-eclampsia, and eclampsia (Tita, 2022). Pre-eclampsia is a major cause of poor pregnancy outcomes (Magee, 2022) as well as leading to long-term negative health outcomes (Roth, 2019). Gestational hypertension is associated with long-term cardiovascular consequences. Therefore, the ISSHP addresses long-term cardiovascular risks of HDP and recommends screening patients 3 months postpartum, to monitor their blood pressure, fasting glucose levels, and lipid profiles (Magee, 2022). Despite these recommendations, HCPs have insufficient knowledge about the increased cardiovascular risks after HDP (Roth, 2019). During the transition to menopause, women’s susceptibility to CVD significantly increases and remains high post-menopause (Okeahialam, 2022). This increased risk is mainly due to accelerated vascular ageing (Nair, 2021), which plays a crucial role in the development of hypertension and atherosclerosis. The prevalence of heart failure with preserved ejection fraction (HFpEF) also increases following menopause, with post-menopausal women comprising the majority of HFpEF patients (Barton, 2020). Patient–healthcare professional engagement presents a valuable opportunity to assess and counsel women about their cardiovascular risk profile (Hodis, 2016). The North American Menopause Society recommends hormone replacement therapy for reducing vasomotor symptoms within ten years of menopause onset in women aged younger than 60 with no contraindications (The Hormone Therapy Position Statement of the North American Menopause Society Advisory Panel, 2022). This live webinar will focus on HDP and menopausal CVD risk and discuss the guidelines for monitoring for cardiovascular risk and management/treatment.

Learning Objectives

After attending this webinar, participants will be able to:

  • • Describe how hypertensive disorders during pregnancy change the woman’s future CVD risk
  • • Outline guideline recommendations for long-term monitoring of blood pressure in patients who had HDP
  • • Describe how women’s CVD risks change after menopause

Target Audience

Clinicians (including cardiologists, internists, and general practitioners), nurse practitioners and other HCPs who manage patients with hypertension and heart failure. Some content of interest to gynaecologists, midwives, nurses involved in women’s health care.

Language

English with voice-over into Russian and Chinese

Continuing Medical Education

The Women’s Health, CVD and Hypertension – Virtual, Italy, 08/11/2024 – 08/11/2024 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

uems-eaccme-logo

The content of the “Women’s Health, CVD and Hypertension” has been certified by the CPD Certification Service as conforming to continuing professional development principles.

Faculty

Rosa Maria Bruno

Rosa Maria Bruno

Professor in Pharmacology
Head of the Unit of Clinical Pharmacology and Women’s Cardiovascular Health
Hopital Européen Georges Pompidou
Université Paris Cité
Paris, France
Biography
Maria Lorenza Muiesan

Maria Lorenza Muiesan

Professor of Internal Medicine
Department of Clinical and Experimental Sciences, University of Brescia
Director Department of Medicine, ASST Spedali Civili Brescia
Past President of the Italian Society of Hypertension
Biography
Stefano Taddei

Stefano Taddei

Professor of Internal Medicine
Director of the Hypertension Unit
Department of Clinical and Experimental Medicine
University of Pisa
Pisa, Italy
Biography

International Committee

Maria Lorenza Muiesan

Maria Lorenza Muiesan

Professor of Internal Medicine
Department of Clinical and Experimental Sciences, University of Brescia
Director Department of Medicine, ASST Spedali Civili Brescia
Past President of the Italian Society of Hypertension
Biography
Šekib Sokolović

Šekib Sokolović

President of the Working Group of HTA and PAH
Member of the Executive Board of the Association of Cardiologist of Bosnia and Herzegovina
Professor and Cardiologist at ASA Hospital Sarajevo
Sarajevo, Bosnia and Herzegovina
Biography

Partnerships & Endorsements

Belgian Hypertension Committee (BHC)

Bosnia and Herzegovina Working Group on Hypertension and PAH (UKBiH)

Chinese Hypertension League (CHL)

Hungarian Society of Hypertension (MHT)

Romanian Society of Hypertension (RSH)

Con il patrocinio della Società Italiana dell'Ipertensione Arteriosa (SIIA)

Agenda

AGENDA

Final Programme

Download Final Programme

FUNDING

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 60 countries and has published 482 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.

· Rosa Maria Bruno ·

Rosa Maria Bruno (MD, PhD) is specialist in Internal Medicine and Hypertension, head of the Unit of Clinical Pharmacology and Women’s Cardiovascular Health at the Hopital Européen Georges Pompidou and full professor in Pharmacology at Université Paris Cité (Paris, France). Her research is focused on novel approaches for the non-invasive evaluation of vascular ageing in hypertension and other diseases, with a focus on sex and gender differences. She is secretary of the Artery Society and treasurer of the ESC Council of Hypertension.

· Maria Lorenza Muiesan ·

Maria Lorenza Muiesan has been full Professor of Internal Medicine, at the Department of Clinical and Experimental Sciences at the University of Brescia since 2005. She is Chairman of the Department of Internal Medicine, ASST Spedali Civili di Brescia. Prof Muiesan graduated in Medicine and Surgery at the University of Milan in 1980, she specialized in Cardiology (1982) and Internal Medicine (1987) at the University of Milan. She has spent few years in prestigious international Research Centers as visiting Research Fellow with the support of institutional grants (MRC, Great Britain), in London, GB, Hammersmith Hospital (1982-1983), in New York, Cornell University (1994), US. Prof Muiesan has lectured internationally on topics related to hypertension and cardiovascular diseases of the European Society of Hypertension, and of the European Society of Cardiology. She is a member of several national and international Scientific Societies (including Societ  Italiana della Ipertensione Arteriosa, Societ  Italiana di Medicina Interna, Societ  Italiana di Cardiologia, European Society of Hypertension, International Society of Hypertension, European Society of Cardiology). Prof Muiesan is currently President of the Italian Society of Hypertension. She is also member of the Council of Hypertension of the European Society of Cardiology. Prof Muiesan has also participated in several randomized multicentre clinical trials in cardiovascular care, and has actively participated to the prospective large observational Vobarno study in East Lombardia (Italy). Scientific Referee or Editorial Board Member of several scientific journals: Hypertension, Circulation, European Heart Journal, Italian Journal of Cardiology, J. Hypertension, Blood Pressure, European Journal of Internal Medicine, Frontiers in Cardiovascular Diseases, Journal of Human Hypertension, Int J Cardiology, High Blood Pressure and CV Prevention). Author of about 800 scientific publications – H-index 56.

· Stefano Taddei ·

Stefano Taddei is Full Professor of Internal Medicine, currently working as Director of the Hypertension Unit at the Department of Clinical and Experimental Medicine of the University of Pisa, Italy. He is a fellow of the European Society of Cardiology, member of the European, International and American Society of Hypertension, the European Society of Clinical Investigation and the High Blood Pressure Council of the American Heart Association. Professor Taddei is an editorial board member for numerous international and national scientific journals, Hypertension, Journal of Hypertension, Journal of Cardiovascular Pharmacology, Blood Pressure and he is Deputy Editor of the European Heart Journal. His main research area is the neuro-humoral control of peripheral arterial circulation in essential and secondary hypertension, with particular emphasis on adrenergic mechanisms, non-adrenergic neurotransmitters, the circulating and vascular renin-angiotensin system and endothelial function. Professor Taddei has participated in numerous clinical studies and is the authors of more than 400 original papers, reviews editorials and book chapters in international scientific journals (H index: 74; Impact Factor: >3000).

· Šekib Sokolović ·

Sokolovic Sekib is a Specialist Internist and Subspecialist Cardiologist at ASA Hospital, Sarajevo, Bosnia and Herzegovina. Born in 1957, he has held previous positions at the University Clinical Center, Clinic for Heart, Blood vessels and Rheumatism, Medical Faculty of Sarajevo and is Vice President of  the Association of Cardiologists in Bosnia and Herzegovina. Prof.  Sekib is an elected fellow of the European Society of Cardiology (ESC) and serves on a number of working groups including myocardium and pericardial disease, heart failure, pulmonary circulation and right ventricular function and coronary pathophysiology and microcirculation. He achieved his diploma as a European Hypertension Specialist in 2013 and is an active member of the European Society of Hypertension (ESH), the European Society for Microcirculation and the Turkish Society of Cardiology. In September 2014, he was awarded the Samsung Clinical Programme.

Join our Newsletter!

Stay in the know with our CME updates

Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.